학술논문
Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)
Document Type
Article
Author
Thomson, D.J.; Slevin, N.J.; Bolton, S.; Garcez, K.; Lee, L.; Price, J.M.; Irlam, J.; Mistry, H.; More, E.; West, C.M.; Baines, H.; Yang, H.; Nutting, C.; Betts, G.; Evans, M.; Melillo, N.; Schipani, S.; Sen, M.; Aynsley, E.; Banner, R.; Barnett, G.; Cardale, K.; Prestwich, R.; Christian, J.; Fresco, L.; Grant, W.; Hartley, A.; Lester, J.; McCloskey, P.; Shenoy, A.; Thiagarajan, S.; Wood, K.
Source
In: International Journal of Radiation Oncology Biology Physics . (International Journal of Radiation Oncology Biology Physics, 1 July 2024, 119(3):771-782)
Subject
Language
English
ISSN
1879355X
03603016
03603016